Table 4. Univariable and multivariable survival analysis by age group.
| Patients <70 years old | Patients ≥70 years old | |||||||
|---|---|---|---|---|---|---|---|---|
| Univariable | Multivariable | Univariable | Multivariable | |||||
| HR (95%CI) | p-value | HR (95%CI) | p-value | HR (95%CI) | p-value | HR (95%CI) | p-value | |
| Gender, Female | 1.01 (0.89–1.32) | 0.41 | 0.95 (0.74–1.23) | 0.72 | ||||
| Site, Gallbladder | 1.37 (1.12–1.68) | 0.003 | 1.10 (0.97–1.48) | 0.10 | 1.03 (0.79–1.34) | 0.81 | ||
| CCI | 0.96 (0.88–1.05) | 0.36 | 0.98 (0.92–1.05) | 0.62 | ||||
| Stage I / Stage II | 0.34 (0.29–0.43) | < .0001 | 0.55 (0.42–0.71) | < .0001 | 0.40 (0.30–0.53) | < .0001 | 0.39 (0.29–0.54) | < .0001 |
| ECOG, ≥2 | 2.90 (2.00–4.22) | < .0001 | 2.45 (1.67–3.59) | < .0001 | 2.78 (2.03–3.81) | < .0001 | 2.05 (1.48–3.84) | < .0001 |
| Treatment | < .0001 | |||||||
| Surgery | 0.16 (0.13–0.21) | < .0001 | 0.20 (0.15–0.27) | < .0001 | 0.27 (0.20–0.37) | < .0001 | 0.29 (0.21–0.41) | < .0001 |
| Palliative chemotherapy | 0.49 (0.39–0.62) | < .0001 | 0.44 (0.34–0.56) | < .0001 | 0.72 (0.53–0.99) | 0.04 | 0.50 (0.36–0.71) | < .0001 |
| Best supportive care | − | − | − | − | ||||
Abbreviations: ECOG PS: European Cooperative Oncology Group Performance Status; CCI: Charlson Co-morbidity index